Figure 5.
The figure presents the comparison among IADT, IADT and ADT for the
resistance group. (A) The dynamics of the competition advantage of
responsive cancer cells toward the resistant cancer cells in patient036 (upper
panel) and all resistant patients with 95% CI (lower panel). (B) The
PFS rate over time with I
ADT, IADT and
ADT. (C) The distribution of TTP with I
ADT, IADT and ADT.